The word 'SAVER' with the letter 'A' and 'V' stylized as a red diamond shape.

The SAVER™: a Novel CPR Adjunct

The Problem

There are over 650,000 cardiac arrest cases per year in the United States, 90% of which end in fatalities. Of the surviving population, only 9% of them survive without neurologic impairment. CPR is a technique that has not changed much since its inception in the 1960s, and while education initiatives and technological advances (e.g. the AED) have occurred in this space, there has been little change to the standard of care.

How might we improve CPR outcomes through the development of a non-invasive, user-friendly CPR adjunct device to be deployed during CPR?

Our Solution

The SAVER is a novel, patent-pending CPR adjunct device that aims to improve CPR outcomes through preferentially redirecting blood perfusion to key areas of the body. Preferentially perfusing key organs such as the heart and brain will increase chances of survival and reduce the potential for neurologic impairment. The SAVER™ is easy-to-use and can be applied to the patient without interrupting current standard of care. The device can be deployed both in the field and in hospital settings, and will ultimately be found wherever an AED is stored.

Research Strategy

The SAVER™ Team is currently engaged in iterative product development at the Medical University of South Carolina. A pilot study in pig models as well as a clinical trial on healthy human controls have also been conducted to validate our proof-of-concept.

Next steps include pursuing a larger research study in partnership with South Carolina EMS departments to validate the SAVER’s viability, usability, and feasibility in the field.

How to Get Involved

Our team is growing rapidly and always looking for new talent, expertise, and collaborators. For more information about how to get involved, please contact us to get plugged in.

The SAVER™ Milestones

Explore key milestones from each year of the
Heartbeat Tech™ journey